FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to dermatology. That is ensured by topically applying a pharmaceutical composition containing 0.001 % to 0.20 % by weight of a prostaglandin F2-alpha (PGF 2α), PGF 2α analogue, selected from latanoprost, travoprost, bimatoprost or tafluprost or combinations thereof, and a pharmaceutically acceptable carrier directly on an area of atrophic cicatrisation.
EFFECT: invention can be used for treating atrophic cutaneous scar in a human.
8 cl, 3 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ACTIVATING WOUND HEALING | 2009 |
|
RU2506092C2 |
| STORAGE OF STABLE PREPARATION OF PROSTAGLANDIN | 2010 |
|
RU2482851C2 |
| ANTIFIBROGENIC COMPOUNDS, METHODS AND USE THEREOF | 2014 |
|
RU2726416C2 |
| METHOD FOR TREATMENT OF BURNS AND SCARS WITH APPLICATION OF TOCOTRIENOL COMPOSITIONS | 2013 |
|
RU2638793C2 |
| PEPTIDES FOR SKIN REJUVENATION AND METHODS OF THEIR USAGE | 2014 |
|
RU2666533C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING WOUND OR SCAR CONTAINING BENZBROMARONE | 2021 |
|
RU2816016C1 |
| SKIN-PENETRATING GLYCOSAMINOGLYCAN COMPOSITIONS FOR TOPICAL APPLICATION IN COSMETICS AND PHARMACY | 2011 |
|
RU2637443C2 |
| COMPOSITIONS AND METHODS OF SKIN CARE | 2009 |
|
RU2517594C2 |
| MEANS FOR CELL REPLACEMENT THERAPY | 2007 |
|
RU2342163C1 |
| METHOD OF TREATING KELOIDS OR HYPERTROPHIC SCARS USING ANTISENSE COMPOUNDS, DIRECTLY ACTING ON CONNECTIVE TISSUE GROWTH FACTOR (CTGF) | 2012 |
|
RU2608655C2 |
